CIK 0001130166 · Non-accelerated filer<br>Smaller reporting company
Bio Green Med Solution, Inc.
Sign in to watch- Tickers
- BGMS BGMSP
- Exchange
- Nasdaq, OTC
- Industry
- Wholesale-Durable Goods, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911766850
- Phone
- 908-517-7330
- Business address
- 200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Cyclacel Pharmaceuticals, Inc., XCYTE THERAPIES INC
Securities
- BGMS Common Stock Nasdaq
- BGMSP Common stock OTC
- 8-K Event Shareholder rights changed
- 4 Open-market buy President & C.E.O. bought 15,902 shares at $0.50 ($7,871)
- 4 Grant or award V.P., Clin. Dev. & reg. Aff. acquired 60,000 shares (grant or award)
- 4 Grant or award President & C.E.O. acquired 75,000 shares (grant or award)
- 4 Grant or award VP, Marketing & Sales acquired 28,000 shares (grant or award)
- 4 Grant or award EVP, Finance, CFO, COO acquired 75,000 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Shareholder rights changed
- CT ORDER Other Confidential Order
- 4 Open-market buy President and C.E.O. bought 30,300 shares at an average $0.62 ($18,805)
- 4 Open-market buy EVP, Finance, CFO, COO bought 12,000 shares at $0.50 ($6,000)
- 4 Open-market sale 10% owner sold 1,150,000 shares at an average $0.55 ($635,280)
- 8-K Event Delisting notice
- 4 Open-market buy President & C.E.O. bought 12,400 shares at an average $0.75 ($9,343)
- 4 Open-market buy President & C.E.O. bought 9,232 shares at $0.73 ($6,721)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
Page 43 of 76 · 1,511 filings